| Item Type | Name |
|
Concept
|
Combined Modality Therapy
|
|
Academic Article
|
Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
|
|
Academic Article
|
Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC).
|
|
Academic Article
|
Variation in post-surgical lumpectomy cavity volume with delay in initiation of breast irradiation because of chemotherapy.
|
|
Academic Article
|
Radiation therapy for heterotopic ossification prophylaxis afer high-risk elbow surgery.
|
|
Academic Article
|
Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985?
|
|
Academic Article
|
Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials.
|
|
Academic Article
|
Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.
|
|
Academic Article
|
A challenge to the therapeutic nihilism of ESPAC-1.
|
|
Academic Article
|
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
|
|
Academic Article
|
Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.
|
|
Academic Article
|
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
|
|
Academic Article
|
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
|
|
Academic Article
|
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704.
|
|
Academic Article
|
Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.
|
|
Academic Article
|
Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer.
|
|
Academic Article
|
Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.
|
|
Academic Article
|
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.
|
|
Academic Article
|
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
|
|
Academic Article
|
Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas.
|
|
Academic Article
|
Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial.
|
|
Academic Article
|
Recent developments in radiotherapy.
|
|
Academic Article
|
The hematopoietic toxicity of regional radiation therapy. Correlations for combined modality therapy with systemic chemotherapy.
|
|
Academic Article
|
Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group.
|
|
Academic Article
|
Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
|
|
Academic Article
|
Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head.
|
|
Academic Article
|
Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group.
|
|
Academic Article
|
The clinical use of multimodality therapy in the management of cancer.
|
|
Academic Article
|
Improved survival for hepatocellular cancer with combination surgery and multimodality treatment.
|
|
Academic Article
|
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.
|
|
Academic Article
|
Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.
|
|
Academic Article
|
Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy.
|
|
Academic Article
|
Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.
|
|
Academic Article
|
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
|
|
Academic Article
|
Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
|
|
Academic Article
|
Adjuvant therapy for pancreatic cancer: back to the future.
|
|
Academic Article
|
Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history.
|
|
Academic Article
|
Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma?
|
|
Academic Article
|
Is there a role for radiotherapy in the management of upper gastrointestinal malignancies?
|
|
Academic Article
|
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
|
|
Academic Article
|
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation.
|
|
Academic Article
|
Acute and late radiotherapy toxicity in patients with inflammatory bowel disease.
|
|
Academic Article
|
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee.
|
|
Academic Article
|
Continuing controversy over adjuvant therapy of pancreatic cancer.
|
|
Academic Article
|
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.
|
|
Academic Article
|
Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.
|
|
Academic Article
|
Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12.
|
|
Academic Article
|
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma.
|
|
Academic Article
|
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031.
|
|
Academic Article
|
ACR Appropriateness Criteria? Resectable Pancreatic Cancer.
|